Óscar Arrieta - Researcher Profile | RDL Research Database

Publications

2 shown

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei , L. Paz-Ares , Leora Horn +25 more

Among patients with advanced nonsquamous NSCLC that had progressed during or after platinum-based chemotherapy, overall survival was longer with nivolumab than with docetaxel. (...

2015 New England Journal of Medicine 9225 citations

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Edward B. Garon , Tudor‐Eliade Ciuleanu , Óscar Arrieta +23 more

2014 The Lancet 1263 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 10,488
Institution: Instituto Nacional de Cancerología

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1164-3779

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.